by University of Maryland
Quantum computers will need analogous hardware to manipulate quantum information. But the design constraints for this new technology are stringent, and today’s most advanced processors can’t be repurposed as quantum devices. That’s because quantum information carriers, dubbed qubits, have to follow different rules laid out by quantum physics.
by Anna Webb - Boise State
Boise State researchers believe graphene foam-enhanced cartilage could one day be used to treat the joint pain caused by osteoarthritis as well as prevent the need for joint replacement. Osteoarthritis is incurable and affects half the U.S. population over the age of 65.
by Lori Dajose - Caltech
Researchers at Caltech have developed an artificial neural network made out of DNA that can solve a classic machine learning problem: correctly identifying handwritten numbers. The work is a significant step in demonstrating the capacity to program artificial intelligence into synthetic biomolecular circuits.
by Arizona State University
More than a century after its discovery, no effective prevention or treatment exists for this progressive deterioration of brain tissue, memory and identity. With more people living to older ages, there is a growing need to clarify Alzheimer’s disease risk factors and disease mechanisms and use this information to find new ways in which to treat and prevent this terrible disorder.
by Jonathan Rabinovitz, Stanford
Thousands of people do not know they have Parkinson’s disease. Eric Horvitz wants them to be able to find out — before the incurable neurodegenerative disorder progresses to its later stages. In his perfect world, they wouldn’t have to interrupt their daily routines. They could stay in their homes and offices, working on their computers, and their online activity would eventually trigger a message: A visit to the doctor is in order.
by Bruce Goldman - Stanford University Neurosciences Institute
A study recently published in the journal Magnetic Resonance in Medicine and co-authored by Stanford life-science research assistant Itamar Terem, then-postdoc Samantha Jane Holdsworth, PhD, (now at the University of Auckland) and several other Stanford colleagues describes a new imaging method that, by means of a kind of strobe-action amplification technique, is able to visually blow up the minute heartbeat-induced pulsations of the brain to produce mind-boggling video sequences such as the one you’ve hopefully taken a peek at here.
by MIT
Nanoscale Kirigami has taken off as a field of research in the last few years; the approach is based on the ancient arts of origami (making 3-D shapes by folding paper) and kirigami (which allows cutting as well as folding) but applied to flat materials at the nanoscale, measured in billionths of a meter.
by PR Newswire
NexLogic Technologies, Inc. has announced the completion of its International Standards Organization (ISO) 14644-1 Class 4/10,000 and the equivalent Federal Standard 209E (FS209E) Class 10 clean room as an integral part of its new microelectronics services and manufacturing capability.
by Decernis
The Food Fraud Database, launched by USP in 2012, helps food manufacturers, retailers, and other stakeholders make informed decisions about the vulnerability of their food ingredients to economically motivated adulteration. This supports compliance with FSMA and GFSI requirements by providing information on the pattern and history of food fraud and the identification of potentially hazardous adulterants.
by PRNEWSWIRE
Neovii pharmaceuticals AG of Rapperswil, Switzerland and Mundipharma have entered into an agreement giving Mundipharma the rights to develop and distribute its polyclonal antibody immunosuppressant Grafalon®, in China and Japan from end October.
by Asia One
ACROMEC Limited (“ACROMEC”, SGX:43F), an established specialist engineering service provider in the field of controlled environments serving mainly the healthcare, biomedical, research and academia sectors, has secured three new contracts totaling approximately S6.2 million.
by Dynacure
Dynacure, a biotechnology company developing new treatments for patients affected by serious orphan disorders, announced today the completion of a €47 million financing round (~US$55 million) to advance its lead program into clinical development. Andera Partners (formerly Edmond de Rothschild Investment Partners) led the financing round, joined by Pontifax, Bpifrance, Kurma Partners and IdInvest Partners.